Short-term physical exercise impacts on the human holobiont obtained by a randomised intervention study.


Journal

BMC microbiology
ISSN: 1471-2180
Titre abrégé: BMC Microbiol
Pays: England
ID NLM: 100966981

Informations de publication

Date de publication:
02 06 2021
Historique:
received: 24 07 2020
accepted: 04 05 2021
entrez: 3 6 2021
pubmed: 4 6 2021
medline: 15 12 2021
Statut: epublish

Résumé

Human well-being has been linked to the composition and functional capacity of the intestinal microbiota. As regular exercise is known to improve human health, it is not surprising that exercise was previously described to positively modulate the gut microbiota, too. However, most previous studies mainly focused on either elite athletes or animal models. Thus, we conducted a randomised intervention study that focused on the effects of different types of training (endurance and strength) in previously physically inactive, healthy adults in comparison to controls that did not perform regular exercise. Overall study duration was ten weeks including six weeks of intervention period. In addition to 16S rRNA gene amplicon sequencing of longitudinally sampled faecal material of participants (six time points), detailed body composition measurements and analysis of blood samples (at baseline and after the intervention) were performed to obtain overall physiological changes within the intervention period. Activity tracker devices (wrist-band wearables) provided activity status and sleeping patterns of participants as well as exercise intensity and heart measurements. Different biometric responses between endurance and strength activities were identified, such as a significant increase of lymphocytes and decrease of mean corpuscular haemoglobin concentration (MCHC) only within the strength intervention group. In the endurance group, we observed a significant reduction in hip circumference and an increase in physical working capacity (PWC). Though a large variation of microbiota changes were observed between individuals of the same group, we did not find specific collective alterations in the endurance nor the strength groups, arguing for microbiome variations specific to individuals, and therefore, were not captured in our analysis. We could show that different types of exercise have distinct but moderate effects on the overall physiology of humans and very distinct microbial changes in the gut. The observed overall changes during the intervention highlight the importance of physical activity on well-being. Future studies should investigate the effect of exercise on a longer timescale, investigate different training intensities and consider high-resolution shotgun metagenomics technology. DRKS, DRKS00015873 . Registered 12 December 2018; Retrospectively registered.

Sections du résumé

BACKGROUND
Human well-being has been linked to the composition and functional capacity of the intestinal microbiota. As regular exercise is known to improve human health, it is not surprising that exercise was previously described to positively modulate the gut microbiota, too. However, most previous studies mainly focused on either elite athletes or animal models. Thus, we conducted a randomised intervention study that focused on the effects of different types of training (endurance and strength) in previously physically inactive, healthy adults in comparison to controls that did not perform regular exercise. Overall study duration was ten weeks including six weeks of intervention period. In addition to 16S rRNA gene amplicon sequencing of longitudinally sampled faecal material of participants (six time points), detailed body composition measurements and analysis of blood samples (at baseline and after the intervention) were performed to obtain overall physiological changes within the intervention period. Activity tracker devices (wrist-band wearables) provided activity status and sleeping patterns of participants as well as exercise intensity and heart measurements.
RESULTS
Different biometric responses between endurance and strength activities were identified, such as a significant increase of lymphocytes and decrease of mean corpuscular haemoglobin concentration (MCHC) only within the strength intervention group. In the endurance group, we observed a significant reduction in hip circumference and an increase in physical working capacity (PWC). Though a large variation of microbiota changes were observed between individuals of the same group, we did not find specific collective alterations in the endurance nor the strength groups, arguing for microbiome variations specific to individuals, and therefore, were not captured in our analysis.
CONCLUSIONS
We could show that different types of exercise have distinct but moderate effects on the overall physiology of humans and very distinct microbial changes in the gut. The observed overall changes during the intervention highlight the importance of physical activity on well-being. Future studies should investigate the effect of exercise on a longer timescale, investigate different training intensities and consider high-resolution shotgun metagenomics technology.
TRIAL REGISTRATION
DRKS, DRKS00015873 . Registered 12 December 2018; Retrospectively registered.

Identifiants

pubmed: 34078289
doi: 10.1186/s12866-021-02214-1
pii: 10.1186/s12866-021-02214-1
pmc: PMC8170780
doi:

Substances chimiques

DNA, Bacterial 0
RNA, Ribosomal, 16S 0

Banques de données

DRKS
['DRKS00015873']

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

162

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : EXC2167
Organisme : Deutsche Forschungsgemeinschaft
ID : FOR5042

Références

J Mol Psychiatry. 2015 Apr 18;3(1):3
pubmed: 26064521
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
Am J Physiol Regul Integr Comp Physiol. 2010 Feb;298(2):R372-7
pubmed: 19923361
J Physiol Pharmacol. 2008 Dec;59 Suppl 7:119-32
pubmed: 19258661
Am J Physiol Gastrointest Liver Physiol. 2012 Jul 15;303(2):G155-68
pubmed: 22517770
J Am Coll Cardiol. 2001 Jan;37(1):153-6
pubmed: 11153730
Exerc Sport Sci Rev. 2019 Apr;47(2):75-85
pubmed: 30883471
Med Sci Sports Exerc. 2007 Apr;39(4):728-34
pubmed: 17414812
Nature. 2012 Jun 13;486(7402):207-14
pubmed: 22699609
Nat Rev Immunol. 2004 Jun;4(6):478-85
pubmed: 15173836
Gut. 2016 Mar;65(3):426-36
pubmed: 26100928
Front Immunol. 2020 Jul 10;11:1421
pubmed: 32754153
PLoS One. 2011;6(7):e22366
pubmed: 21811592
Gut. 1987 May;28(5):583-7
pubmed: 3596339
ISME J. 2012 Aug;6(8):1621-4
pubmed: 22402401
Oxid Med Cell Longev. 2017;2017:3831972
pubmed: 28357027
Nat Rev Immunol. 2008 Jun;8(6):411-20
pubmed: 18469830
Genome Biol. 2014;15(12):550
pubmed: 25516281
Eur J Neurosci. 2004 Nov;20(10):2580-90
pubmed: 15548201
Microbiome. 2016 Aug 08;4(1):42
pubmed: 27502158
Nat Genet. 2016 Nov;48(11):1396-1406
pubmed: 27723756
Microorganisms. 2019 Jan 10;7(1):
pubmed: 30634578
J Cell Physiol. 2017 Feb;232(2):257-269
pubmed: 27381298
J Physiol. 2009 Dec 1;587(Pt 23):5551-8
pubmed: 19736305
J Physiol. 2017 May 1;595(9):2915-2930
pubmed: 27748956
Genome Med. 2018 Feb 22;10(1):12
pubmed: 29471863
Curr Opin Gastroenterol. 2015 Jan;31(1):69-75
pubmed: 25394236
Front Nutr. 2020 Jan 10;6:191
pubmed: 31998739
Nutr Res Pract. 2010 Aug;4(4):259-69
pubmed: 20827340
Annu Rev Immunol. 2010;28:623-67
pubmed: 20192812
Med Sci Sports Exerc. 2018 Apr;50(4):747-757
pubmed: 29166320
Brain Res. 2006 Nov 22;1121(1):59-65
pubmed: 17010953
J Sci Med Sport. 2019 Sep;22(9):1059-1064
pubmed: 31053425
Nat Med. 2019 Jul;25(7):1104-1109
pubmed: 31235964
Physiol Rev. 2019 Oct 1;99(4):1877-2013
pubmed: 31460832
PLoS One. 2017 Feb 10;12(2):e0171352
pubmed: 28187199
J Appl Physiol (1985). 2008 Oct;105(4):1023-5
pubmed: 18719229
Trends Neurosci. 2009 May;32(5):283-90
pubmed: 19349082
Handb Clin Neurol. 2013;117:147-60
pubmed: 24095123
Nat Med. 2019 Sep;25(9):1442-1452
pubmed: 31477907
PM R. 2012 Nov;4(11):797-804
pubmed: 23174541
Microbiome. 2017 Aug 10;5(1):98
pubmed: 28797298
Gut. 2014 Dec;63(12):1913-20
pubmed: 25021423
Br J Sports Med. 2020 Nov 3;:
pubmed: 33144349

Auteurs

Lucas Moitinho-Silva (L)

Institute of Clinical Molecular Biology (IKMB), Christian-Albrechts-University of Kiel, Rosalind-Franklin-Str. 12, 24105, Kiel, Germany.
Department of Dermatology, Quincke Research Center, University Hospital Schleswig- Holstein, Kiel, Germany.

Michelle Wegener (M)

Institute of Sport Science, Christian-Albrechts-University of Kiel, Kiel, Germany.

Sandra May (S)

Institute of Clinical Molecular Biology (IKMB), Christian-Albrechts-University of Kiel, Rosalind-Franklin-Str. 12, 24105, Kiel, Germany.

Florian Schrinner (F)

Institute of Clinical Molecular Biology (IKMB), Christian-Albrechts-University of Kiel, Rosalind-Franklin-Str. 12, 24105, Kiel, Germany.

Awais Akhtar (A)

Institute of Clinical Molecular Biology (IKMB), Christian-Albrechts-University of Kiel, Rosalind-Franklin-Str. 12, 24105, Kiel, Germany.

Teide J Boysen (TJ)

Institute of Clinical Molecular Biology (IKMB), Christian-Albrechts-University of Kiel, Rosalind-Franklin-Str. 12, 24105, Kiel, Germany.

Eva Schaeffer (E)

Department of Neurology, University Hospital Schleswig-Holstein (UKSH), Kiel, Germany.

Clint Hansen (C)

Department of Neurology, University Hospital Schleswig-Holstein (UKSH), Kiel, Germany.

Timo Schmidt (T)

Department of Neurology, University Hospital Schleswig-Holstein (UKSH), Kiel, Germany.

Malte C Rühlemann (MC)

Institute of Clinical Molecular Biology (IKMB), Christian-Albrechts-University of Kiel, Rosalind-Franklin-Str. 12, 24105, Kiel, Germany.

Matthias Hübenthal (M)

Department of Dermatology, Quincke Research Center, University Hospital Schleswig- Holstein, Kiel, Germany.

Philipp Rausch (P)

Institute of Clinical Molecular Biology (IKMB), Christian-Albrechts-University of Kiel, Rosalind-Franklin-Str. 12, 24105, Kiel, Germany.

Mustafa T Kondakci (MT)

Institute of Sport Science, Christian-Albrechts-University of Kiel, Kiel, Germany.

Walter Maetzler (W)

Department of Neurology, University Hospital Schleswig-Holstein (UKSH), Kiel, Germany.

Stephan Weidinger (S)

Department of Dermatology, Quincke Research Center, University Hospital Schleswig- Holstein, Kiel, Germany.

Matthias Laudes (M)

Department of Internal Medicine I, University Hospital Schleswig-Holstein (UKSH), Kiel, Germany.

Philip Süß (P)

Department of Internal Medicine I, University Hospital Schleswig-Holstein (UKSH), Kiel, Germany.

Dominik Schulte (D)

Department of Internal Medicine I, University Hospital Schleswig-Holstein (UKSH), Kiel, Germany.

Ralf Junker (R)

Institute of Clinical Chemistry, Kiel University, Kiel, Germany.

Felix Sommer (F)

Institute of Clinical Molecular Biology (IKMB), Christian-Albrechts-University of Kiel, Rosalind-Franklin-Str. 12, 24105, Kiel, Germany.

Burkhard Weisser (B)

Institute of Sport Science, Christian-Albrechts-University of Kiel, Kiel, Germany.

Corinna Bang (C)

Institute of Clinical Molecular Biology (IKMB), Christian-Albrechts-University of Kiel, Rosalind-Franklin-Str. 12, 24105, Kiel, Germany. c.bang@ikmb.uni-kiel.de.
Department of Dermatology, Quincke Research Center, University Hospital Schleswig- Holstein, Kiel, Germany. c.bang@ikmb.uni-kiel.de.

Andre Franke (A)

Institute of Clinical Molecular Biology (IKMB), Christian-Albrechts-University of Kiel, Rosalind-Franklin-Str. 12, 24105, Kiel, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH